SSA
RMD icon

Schonfeld Strategic Advisors’s ResMed RMD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.87M Buy
+17,240
New +$4.3M 0.03% 574
2025
Q4 		– Sell
-5,806
Closed -$1.59M – 2516
2025
Q3 		$1.59M Buy
+5,806
New +$1.59M 0.01% 1158
2025
Q2 		– Sell
-10,527
Closed -$2.36M – 2461
2025
Q1 		$2.36M Buy
+10,527
New +$2.46M 0.01% 884
2024
Q3 		– Sell
-2,402
Closed -$460K – 2361
2024
Q2 		$460K Buy
+2,402
New +$487K ﹤0.01% 1524
2023
Q4 		– Sell
-8,740
Closed -$1.29M – 2165
2023
Q3 		$1.29M Sell
8,740
-23,166
-73% -$4.19M 0.01% 937
2023
Q2 		$6.97M Buy
+31,906
New +$7.11M 0.06% 423
2023
Q1 		– Sell
-15,834
Closed -$3.3M – 2564
2022
Q4 		$3.3M Buy
15,834
+14,628
+1,213% +$3.21M 0.03% 629
2022
Q3 		$263K Buy
+1,206
New +$274K ﹤0.01% 2168
2022
Q1 		– Sell
-5,600
Closed -$1.46M – 2877
2021
Q4 		$1.46M Buy
5,600
+2,700
+93% +$701K 0.01% 790
2021
Q3 		$764K Buy
+2,900
New +$793K 0.01% 1074
2021
Q2 		– Sell
-5,100
Closed -$990K – 2248
2021
Q1 		$990K Buy
+5,100
New +$1.02M 0.01% 896
2020
Q4 		– Sell
-25,000
Closed -$4.29M – 1834
2020
Q3 		$4.29M Buy
+25,000
New +$4.62M 0.08% 333
2020
Q2 		– Sell
-1,816
Closed -$267K – 1514
2020
Q1 		$267K Buy
+1,816
New +$289K 0.02% 799
2019
Q2 		– Sell
-6,400
Closed -$666K – 1217
2019
Q1 		$666K Buy
6,400
+4,604
+256% +$475K 0.02% 616
2018
Q4 		$205K Sell
1,796
-9,104
-84% -$975K 0.01% 937
2018
Q3 		$1.26M Buy
+10,900
New +$1.19M 0.06% 381
2018
Q2 		– Sell
-3,626
Closed -$357K – 932
2018
Q1 		$357K Sell
3,626
-9,627
-73% -$910K 0.03% 547
2017
Q4 		$1.12M Buy
+13,253
New +$1.09M 0.09% 285
2016
Q2 		– Sell
-12,910
Closed -$746K – 519
2016
Q1 		$746K Buy
+12,910
New +$731K 0.3% 93

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schonfeld Strategic Advisors's RMD Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in ResMed (RMD) in Q1 2026: 17,240 shares worth $3.87M. The stake represents 0.03% of the portfolio and ranks #574 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in RMD as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in RMD in Q1 2016 and has held it in 19 quarters since. The position peaked at $6.97M in Q2 2023. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Schonfeld Strategic Advisors held 17,240 shares of ResMed worth $3.87M as of Q1 2026.
  • ResMed was a new Schonfeld Strategic Advisors position in Q1 2026.
  • ResMed made up 0.03% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #574 holding.
  • Schonfeld Strategic Advisors first reported a position in ResMed in Q1 2016 and has held it in 19 quarters since.
  • Schonfeld Strategic Advisors's ResMed position peaked at $6.97M in Q2 2023.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.